DOP2011000197A - Derivados de arilciclopropilacetamida utiles como activadores de glucoquinasa - Google Patents

Derivados de arilciclopropilacetamida utiles como activadores de glucoquinasa

Info

Publication number
DOP2011000197A
DOP2011000197A DO2011000197A DO2011000197A DOP2011000197A DO P2011000197 A DOP2011000197 A DO P2011000197A DO 2011000197 A DO2011000197 A DO 2011000197A DO 2011000197 A DO2011000197 A DO 2011000197A DO P2011000197 A DOP2011000197 A DO P2011000197A
Authority
DO
Dominican Republic
Prior art keywords
glucoquinase
arilciclopropilacetamide
activators
derivatives
useful
Prior art date
Application number
DO2011000197A
Other languages
English (en)
Inventor
Francisco Javier Agejas-Chicharro
Melendo Ana Belen Bueno
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DOP2011000197A publication Critical patent/DOP2011000197A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Un compuesto de la fórmula: y composiciones farmacéuticas para el tratamiento de diabetes
DO2011000197A 2008-12-19 2011-06-17 Derivados de arilciclopropilacetamida utiles como activadores de glucoquinasa DOP2011000197A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08380341 2008-12-19
US15378109P 2009-02-19 2009-02-19

Publications (1)

Publication Number Publication Date
DOP2011000197A true DOP2011000197A (es) 2011-09-15

Family

ID=40545955

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2011000197A DOP2011000197A (es) 2008-12-19 2011-06-17 Derivados de arilciclopropilacetamida utiles como activadores de glucoquinasa

Country Status (34)

Country Link
US (1) US8063079B2 (es)
EP (1) EP2379517B1 (es)
JP (1) JP5497064B2 (es)
KR (1) KR101290437B1 (es)
CN (1) CN102256952B (es)
AR (1) AR074470A1 (es)
AU (1) AU2009335931B2 (es)
BR (1) BRPI0923183B1 (es)
CA (1) CA2746746C (es)
CO (1) CO6382120A2 (es)
CR (1) CR20110342A (es)
DK (1) DK2379517T3 (es)
DO (1) DOP2011000197A (es)
EA (1) EA019055B1 (es)
EC (1) ECSP11011150A (es)
ES (1) ES2435242T3 (es)
HR (1) HRP20130983T1 (es)
IL (1) IL213210A (es)
JO (1) JO2979B1 (es)
MA (1) MA32902B1 (es)
MX (1) MX2011006434A (es)
MY (1) MY180567A (es)
NZ (1) NZ592930A (es)
PA (1) PA8851901A1 (es)
PE (1) PE20120339A1 (es)
PL (1) PL2379517T3 (es)
PT (1) PT2379517E (es)
SG (1) SG172256A1 (es)
SI (1) SI2379517T1 (es)
TN (1) TN2011000294A1 (es)
TW (1) TWI395748B (es)
UA (1) UA104742C2 (es)
WO (1) WO2010080333A1 (es)
ZA (1) ZA201103944B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102959076B (zh) 2010-03-31 2015-09-16 斯克里普斯研究所 重编程细胞
CN105899192B (zh) 2013-11-22 2019-08-13 国立大学法人东京大学 药物递送用载体、偶联物及含有这些成分的组合物以及它们的施予方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02010745A (es) 2000-05-03 2003-03-10 Hoffmann La Roche Activadores de glucocinasa heteroaromaticos de alquinil-fenilo.
DK1282611T3 (da) 2000-05-08 2005-02-14 Hoffmann La Roche Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer
WO2001085707A1 (en) 2000-05-08 2001-11-15 F. Hoffmann-La Roche Ag Para-amine substituted phenylamide glucokinase activators
MY141521A (en) * 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
DE60336850D1 (en) 2003-01-06 2011-06-01 Lilly Co Eli Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
PL378117A1 (pl) 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
US7262196B2 (en) 2003-02-11 2007-08-28 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
US7432287B2 (en) * 2003-02-26 2008-10-07 Banyu Pharmeceutical Co., Ltd. Heteroarylcarbamoylbenzene derivative
MXPA06012008A (es) 2004-04-21 2007-01-25 Prosidion Ltd Compuestos de amida tri(ciclo) sustituidos.
KR100890695B1 (ko) 2004-08-12 2009-03-26 프로시디온 리미티드 치환된 페닐아세트아미드 및 글루코키나제 활성화제로서의그의 용도
EP1824835A1 (en) * 2004-12-03 2007-08-29 Novo Nordisk A/S Heteroaromatic glucokinase activators
RU2008103142A (ru) * 2005-07-01 2009-08-10 Новартис АГ (CH) Комбинация органических соединений
JP4033409B1 (ja) 2005-07-11 2008-01-16 田辺三菱製薬株式会社 オキシム誘導体及びその製法
JP2009504621A (ja) * 2005-08-09 2009-02-05 アストラゼネカ アクチボラグ 糖尿病の処置のためのヘテロアリールカルバモイルベンゼン誘導体
WO2007051845A1 (en) 2005-11-03 2007-05-10 Prosidion Ltd Tricyclo substituted amides
US20080293741A1 (en) * 2005-11-03 2008-11-27 Matthew Colin Thor Fyfe Tricyclo Substituted Amides as Glucokinase Modulators
WO2007051846A1 (en) 2005-11-03 2007-05-10 Prosidion Ltd Tricyclo substituted amides
KR20090025358A (ko) * 2006-07-24 2009-03-10 에프. 호프만-라 로슈 아게 글루코키나제 활성화제로서의 피라졸
EP2105435A4 (en) * 2007-01-10 2011-06-15 Mitsubishi Tanabe Pharma Corp Hydrazone derivative
KR101608259B1 (ko) 2008-04-28 2016-04-01 교린 세이야꾸 가부시키 가이샤 시클로펜틸아크릴산아미드 유도체

Also Published As

Publication number Publication date
JO2979B1 (en) 2016-03-15
BRPI0923183B1 (pt) 2019-03-19
CA2746746C (en) 2013-09-24
IL213210A (en) 2015-03-31
BRPI0923183A2 (pt) 2016-02-16
AR074470A1 (es) 2011-01-19
ZA201103944B (en) 2012-11-28
AU2009335931B2 (en) 2012-05-31
JP5497064B2 (ja) 2014-05-21
WO2010080333A1 (en) 2010-07-15
JP2012512874A (ja) 2012-06-07
ES2435242T3 (es) 2013-12-17
BRPI0923183A8 (pt) 2017-09-12
IL213210A0 (en) 2011-07-31
TN2011000294A1 (en) 2012-12-17
US8063079B2 (en) 2011-11-22
EP2379517B1 (en) 2013-08-28
PA8851901A1 (es) 2010-07-27
TWI395748B (zh) 2013-05-11
PL2379517T3 (pl) 2014-01-31
MA32902B1 (fr) 2011-12-01
CN102256952A (zh) 2011-11-23
SI2379517T1 (sl) 2013-10-30
SG172256A1 (en) 2011-07-28
CN102256952B (zh) 2013-12-11
TW201029999A (en) 2010-08-16
KR101290437B1 (ko) 2013-07-29
NZ592930A (en) 2013-01-25
DK2379517T3 (da) 2013-09-30
CO6382120A2 (es) 2012-02-15
KR20110086751A (ko) 2011-07-29
HRP20130983T1 (hr) 2013-11-22
PT2379517E (pt) 2013-11-21
MY180567A (en) 2020-12-02
EA019055B1 (ru) 2013-12-30
EA201170845A1 (ru) 2011-12-30
US20100160395A1 (en) 2010-06-24
AU2009335931A1 (en) 2011-07-07
CA2746746A1 (en) 2010-07-15
ECSP11011150A (es) 2011-07-29
PE20120339A1 (es) 2012-04-16
EP2379517A1 (en) 2011-10-26
UA104742C2 (uk) 2014-03-11
CR20110342A (es) 2011-09-14
MX2011006434A (es) 2011-07-19

Similar Documents

Publication Publication Date Title
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
CO6430459A2 (es) Derivados de prolina como inhibidores de catepsina
DOP2012000006A (es) Agonista de gpr119
CO6362015A2 (es) Derivados de acido 1-amino-2ciclobutiletilboronico
ECSP11011151A (es) Compuestos purina
CY1117143T1 (el) Νεα καρβονυλιωμενα (αζα)κυκλοεξανια ως προσδετες του d3 υποδοχεα ντοπαμινης
CR20110467A (es) Derivados de benzofuranilo como inhibidores de la glucoquinasa
MX2011005934A (es) Compuestos organicos.
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
CR20110046A (es) Amidofenoxiindazoles utiles como inhibidores de c-met
ECSP11011526A (es) Aril-piridinas como inhibidoras de sintasa de aldosterona
CR20120659A (es) Derivados de piperidinona como inhibidores mdm2 para el tratamiento de cáncer
CR20120295A (es) Triazolopiridinas
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
CO6321252A2 (es) Derivados de quinoxalindiona
CL2011000846A1 (es) Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
BR112015007310A2 (pt) compostos, composição farmacêutica, uso de um composto de fórmula (i) e uso de uma composição farmacêutica
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.
MX360330B (es) Regimen de administracion para nitrocatecoles.
CL2011000258A1 (es) Compuestos derivados de fenilamino-isonicotinamida; inhibidores de mek; composicion farmaceutica y uso para el tratamiento de enfermedades hiperproliferativas tales como cancer e inflamacion.
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
CL2011003123A1 (es) Compuestos derivados de ciclopentanamida sustituidos; composicion farmaceutica; proceso de obtencion; y uso en el tratamiento o la profilaxis de la diabetes, aterosclerosis, entre otras.
ATE546448T1 (de) Urotensin-ii-rezeptorantagonisten